NCT05387980View on ClinicalTrials.gov

A Study to Learn About the Study Medicine (CIBINQO) in People With Atopic Dermatitis.

RecruitingOBSERVATIONAL

Enrollment

1,200

Participants

Timeline

Start Date

April 19, 2022

Primary Completion Date

August 2, 2028

Study Completion Date

August 2, 2028

Conditions

Atopic Dermatitis

Interventions

DRUG

CIBINQO

Patients receiving CIBINQO tablets by mouth for the treatment of Atopic Dermatitis.

Trial Locations (1)

Unknown

RECRUITING

Pfizer Local Country Office, Tokyo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY

NCT05387980 - A Study to Learn About the Study Medicine (CIBINQO) in People With Atopic Dermatitis. | Biotech Hunter | Biotech Hunter